Cargando...
Metabolomic and Lipidomic Biomarkers for Premalignant Liver Disease Diagnosis and Therapy
In recent years, there has been a plethora of attempts to discover biomarkers that are more reliable than α-fetoprotein for the early prediction and prognosis of hepatocellular carcinoma (HCC). Efforts have involved such fields as genomics, transcriptomics, epigenetics, microRNA, exosomes, proteomic...
Gardado en:
| Publicado en: | Metabolites |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
MDPI
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7074571/ https://ncbi.nlm.nih.gov/pubmed/32012846 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/metabo10020050 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|